2-amino-3-(1H-imidazol-5-yl)propanoic acid;hydron;dichloride

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-amino-3-(1H-imidazol-5-yl)propanoic acid;hydron;dichloride
• 化学式: C6H11Cl2N3O2
• mdl: MFCD00035203
• 分子量: 228.07
• InChiKey: XEJCDBUNISUVGZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.29
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  92
• 氢给体数：
  5
• 氢受体数：
  6

文献信息

• AMIDE COMPOUNDS, METHODS FOR PREPARATION, AND USE THEREOF AS AGENTS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY RNA- AND/OR DNA-CONTAINING VIRUSES, AND CONCOMITANT DISEASES
  申请人：OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU "PHARMENTERPRISES"

  公开号：US20170183318A1

  公开（公告）日：2017-06-29

  The present invention relates to medicine and includes a method for preventing and treating diseases caused by RNA- and DNA-containing viruses, and concomitant diseases, wherein the method comprises the use of an effective amount of compounds of general formula I or pharmaceutically acceptable salts thereof. The invention also relates to methods for preparing said compounds, pharmaceutical compositions for the prevention or treatment of diseases caused by RNA- and DNA-containing viruses, said compositions comprising an effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof. The invention addresses the object of providing a novel agent effective in the treatment of diseases caused by an RNA-containing virus belonging to the Enterovirus, Metapneumovirus, Pneumovirus, Respirovirus, or Alfa-coronavirus genus, and/or by a DNA-containing virus belonging to the Adenoviridae and/or Herpesviridae family, and in the prevention and treatment of asthma exacerbation, chronic obstructive pulmonary disease, mucoviscidosis, conjunctivitis, gastroenteritis, hepatitis, myocarditis; in the prevention and treatment of rhinorrhea, acute and infectious rhinitis, pharyngitis, nasopharyngitis, tonsillitis, laryngitis, laryngotracheitis, laryngotracheobronchitis, bronchitis, bronchiolitis, pneumonia, or airway obstructive syndrome.

  本发明涉及医学，包括一种用于预防和治疗由RNA-和DNA-含病毒引起的疾病以及相关疾病的方法，其中该方法包括使用通式I的化合物或其药用可接受盐的有效量。该发明还涉及制备上述化合物的方法，用于预防或治疗由RNA-和DNA-含病毒引起的疾病的药物组合物，该组合物包括通式I的化合物或其药用可接受盐的有效量。该发明解决了提供一种新型药剂的目标，用于治疗属于肠病毒、副呼吸道病毒、呼吸道病毒、呼吸道病毒或阿尔法冠状病毒属的RNA-含病毒引起的疾病，和/或属于腺病毒科和/或疱疹病毒科的DNA-含病毒引起的疾病，并在预防和治疗哮喘急性发作、慢性阻塞性肺疾病、黏液囊病、结膜炎、胃肠炎、肝炎、心肌炎；在预防和治疗流涕、急性和感染性鼻炎、咽炎、鼻咽炎、扁桃体炎、喉炎、喉气管炎、喉气管支气管炎、支气管炎、支气管炎、肺炎或气道梗阻综合征方面具有有效性。
• CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE
  申请人：Lee Wai Mun

  公开号：US20090130849A1

  公开（公告）日：2009-05-21

  A composition and associated method for chemical mechanical planarization (or other polishing) is described. The composition contains an amidoxime compound and water. The composition may also contain an abrasive and a compound with oxidation and reduction potential. The composition is useful for attaining improved removal rates for metal, including copper, barrier material, and dielectric layer materials in metal CMP. The composition is particularly useful in conjunction with the associated method for metal CMP applications.

  本文描述了一种化学机械平整化（或其他抛光）的组合物及其相关方法。该组合物含有一种酰胺肟化合物和水。该组合物还可以含有磨料和具有氧化还原潜力的化合物。该组合物可用于在金属CMP中获得改进的金属去除速率，包括铜、屏障材料和金属CMP中的介电层材料。该组合物在金属CMP应用的相关方法中特别有用。
• COPPER CMP POLISHING PAD CLEANING COMPOSITION COMPRISING OF AMIDOXIME COMPOUNDS
  申请人：Lee Wai Mun

  公开号：US20090137191A1

  公开（公告）日：2009-05-28

  The present invention relates to methods of using amidoxime compositions for cleaning polishing pads, particularly after chemical mechanical planarization or polishing is provided. A polishing pad is cleaned of Cu CMP by-products, subsequent to or during planarizing a wafer, to reduce pad-glazing by applying to the polishing pad surface a composition comprising an aqueous amidoxime compound solution in water.

  本发明涉及使用氨基甲酰肼组合物清洁抛光垫的方法，特别是在化学机械平面化或抛光后提供的方法。在平面化晶片的过程中或之后，通过在抛光垫表面涂布含有水的氨基甲酰肼化合物溶液的组合物，清除铜化学机械抛光副产物，以减少垫面光泽。
• Renin inhibitory peptides
  申请人：BEECHAM GROUP PLC

  公开号：EP0350163A2

  公开（公告）日：1990-01-10

  Compounds of formula (I), and pharmaceutically acceptable salts thereof: wherein Z₁, Z₂, Z₃ and the carbon atoms to which Z₁ and Z₃ are attached, form a 5-membered non-aromatic heterocyclic ring; E is absent or is (CH₂)n or CH(CH₂)n-1 wherein n is 1 to 4; A is -CONH-, -NHCO-, -COO-, -S(O)r- wherein r is 0, 1 or 2, or -CH₂-; p is 0, 1 or 2; q is 0 or 1; Rz is hydrogen, C₁₋₆ alkyl or, when A is -CH₂-, hydroxy; Ra and Rb are independently selected from hydrogen or a substituent; R₁ is CH₂R₉ wherein R₉ is optionally substituted aryl or heteroaryl; R₂ is CHR₁₀R₁₁ wherein R₁₀ is hydrogen or methyl and R₁₁ is C₁₋₆ alkyl, C₃₋₈ cycloalkyl, optionally substituted aryl or heteroaryl, or R₁₁ is amino, C₂₋₇ alkanoylamino, 2-oxopyrrolidinyl, 2-oxopiperidinyl or C₁₋₆ alkoxycarbonylamino; R₃ is CH₂R₁₂ wherein R₁₂ is C₁₋₆ alkyl or C₃₋₈ cycloalkyl; R₄ is C₁₋₆ alkyl or C₃₋₈ cycloalkyl; and the dashed line represents an optional bond (when E is present); which are renin inhibitors, useful in the treatment of hypertension.

  式 (I) 的化合物及其药学上可接受的盐类： 其中 Z₁、Z₂、Z₃ 和连接 Z₁ 和 Z₃ 的碳原子形成 5 元非芳杂环； E 不存在或为 (CH₂)n 或 CH(CH₂)n-1，其中 n 为 1 至 4； A 是-CONH-、-NHCO-、-COO-、-S(O)r-（其中 r 是 0、1 或 2）或-CH₂-； p 是 0、1 或 2 q 是 0 或 1； Rz 是氢、C₁₋₆烷基或（当 A 是-CH₂-时）羟基； Ra 和 Rb 分别独立地选自氢或取代基； R₁ 是 CH₂R₉，其中 R₉ 是任选取代的芳基或杂芳基； R₂ 是 CHR₁₀R₁₁ 其中 R₁₀ 是氢或甲基，R₁₁ 是 C₁₋₆ 烷基、C₃₋₈ 环烷基、任选取代的芳基或杂芳基、或 R₁₁ 是氨基、C₂₋₇ 烷酰氨基、2-氧代吡咯烷基、2-氧代哌啶基或 C₁₋₆ 烷氧羰基氨基； R₃ 是 CH₂R₁₂，其中 R₁₂ 是 C₁₋₆ 烷基或 C₃₋₈ 环烷基； R₄ 是 C₁₋₆ 烷基或 C₃₋₈ 环烷基；以及 虚线代表任选键（当 E 存在时）；它们是肾素抑制剂，可用于治疗高血压。
• A catalyst for asymmetric induction
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：EP0420658A2

  公开（公告）日：1991-04-03

  (S)-cyanohydrins are produced by asymmetric addition of hydrogen cyanide to aldehydes in the presence of a catalyst of cyclo-[(S)-leucyl-(S)-histidyl].

  (S)-cyanohydrins 是在环-[(S)-亮氨酰-(S)-组氨酰]催化剂存在下，通过氰化氢与醛的不对称加成反应生成的。